在患有帕金森病的患者中,早期启动多巴胺替代疗法有利于运动症状
Xin Li1,2, Zhao-Ying Dong3,2, Meng Dong1
1Tianjin Medical University, Tianjin, China.
Frontiers in human neuroscience
|May 29, 2024
概括
在帕金森病 (PD) 中延迟多巴胺替代疗法加速了运动症状的进展. 早期开始治疗对于管理PD运动和非运动症状至关重要,改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 的进展通常是缓慢的,但延迟治疗对其进展的影响仍在争论中.
- 了解治疗时间和疾病严重程度之间的关系对于优化患者护理至关重要.
研究的目的:
- 调查多巴胺替代疗法的开始与帕金森病中运动和非运动症状的进展之间的相关性.
- 评估延迟治疗对PD患者临床表现严重性的影响.
主要方法:
- 一组155名新诊断的 (de novo) 帕金森病患者与165名已经接受多巴胺替代疗法的患者进行了比较.
- 记录了患者的特征,包括年龄,发病年龄,疾病持续时间和治疗开始时间.
- 使用运动障碍学会统一帕金森病评级尺度 (MDS-UPDRS) 评估了运动和非运动症状的严重程度.
主要成果:
- 开始多巴胺疗法后的患者在调整混因素后,MDS-UPDRS运动得分比早期接受治疗的患者增加得更快.
- 进展到Hoehn和Yahr第3阶段的累积发病率显著更高,并且在未经治疗的新组中更早发生.
- 治疗开始的时间解释了前未使用药物患者运动症状严重程度变化的很大一部分 (20.1%) .
结论:
- 早期启动多巴胺替代疗法对帕金森病患者具有有益影响.
- 延迟治疗可能会对运动和非运动症状产生负面影响,这表明患者的整体状况可能受到损害.
- 早期识别PD症状和及时诊断对于有效的治疗和管理至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
01:15Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
309
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
309
01:22Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
174
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
174